More than 80 countries have expressed interest in acquiring Recombinant Human Interferon Alpha 2b, a Cuban product that has gained fame for its results in the therapy of coronavirus positive patients. Of the patients with COVID-19 on the island, 93.4% had been treated with Heberon―trade name of Interferon Alfa 2b―, according to data revealed by … Continue reading Global interest in Cuban Interferon increases